{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:28:43Z","timestamp":1758040123703,"version":"3.44.0"},"reference-count":49,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000191","name":"Kidney Foundation of Canada","doi-asserted-by":"publisher","award":["Kidney Health Research Grant"],"award-info":[{"award-number":["Kidney Health Research Grant"]}],"id":[{"id":"10.13039\/501100000191","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Medicine, Western University","award":["Research Grant"],"award-info":[{"award-number":["Research Grant"]}]},{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","award":["Innovations Grant"],"award-info":[{"award-number":["Innovations Grant"]}],"id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,8,19]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Patients receiving haemodialysis are at very high risk of fragility fracture, yet there are no proven treatments for fracture prevention. We will advance a pilot study on the feasibility of a large, pragmatic, randomised controlled trial (RCT) of denosumab for fragility fracture prevention in haemodialysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial design<\/jats:title>\n                  <jats:p>PRevEnting FracturEs in REnal Disease-1 is a pragmatic, open-label, pilot study of an RCT of a denosumab care pathway embedded in routine care haemodialysis centres.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We will recruit at least 60 participants at high risk of fracture from at least 6 haemodialysis centres in Ontario, Canada. They must be aged 40 years or older, have access to provincial drug coverage, have appropriate baseline calcium and parathyroid hormone levels and be deemed suitable for denosumab by their kidney care provider. Participants will be randomised 1:1 to denosumab (with supports to mitigate hypocalcaemia) versus usual care using block randomisation by a central statistician (computer-generated sequence). Primary outcomes include recruitment feasibility and adherence. Secondary outcomes include safety (hypocalcaemia) and participant satisfaction with our protocol and processes. Study investigators and data analysts will be blind to treatment allocation.<\/jats:p>\n                  <jats:p>We will present results descriptively. The trial was approved by Clinical Trials Ontario and local research ethics boards across study sites.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Primary and secondary outcomes will be published on trial completion.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This pilot will inform the feasibility of conducting a large-scale, efficiently run, pragmatic RCT to test whether a denosumab care pathway safely reduces the risk of fragility fracture in patients receiving haemodialysis. Results have the potential to transform fracture care in real-world patients with kidney and metabolic bone disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05096195\">NCT05096195<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-097195","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:00:35Z","timestamp":1757570435000},"page":"e097195","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["PRevEnting FracturEs in REnal Disease-1 (PREFERRED-1): protocol for a pilot study of a pragmatic, randomised controlled trial of denosumab for the prevention of fragility fractures in haemodialysis"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05096195","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-5597","authenticated-orcid":false,"given":"Kristin K","family":"Clemens","sequence":"first","affiliation":[{"name":"Medicine, Western University, London, Ontario, Canada"},{"name":"ICES Western, London, Ontario, Canada"},{"name":"Lawson Research Institute, London, Ontario, Canada"},{"name":"Centre for Diabetes, Endocrinology and Metabolism, St. Joseph's Health Care London, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cowan","sequence":"additional","affiliation":[{"name":"Medicine, Western University, London, Ontario, Canada"},{"name":"ICES Western, London, Ontario, Canada"},{"name":"Nephrology, London Health Sciences Centre, London, Ontario, Canada"},{"name":"Lawson Health Sciences Centre Research Institute, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Dixon","sequence":"additional","affiliation":[{"name":"Medicine, Western University, London, Ontario, Canada"},{"name":"ICES Western, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyla","family":"Naylor","sequence":"additional","affiliation":[{"name":"Medicine, Western University, London, Ontario, Canada"},{"name":"ICES Western, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A","family":"Weir","sequence":"additional","affiliation":[{"name":"Medicine, Western University, London, Ontario, Canada"},{"name":"ICES Western, London, Ontario, Canada"},{"name":"Nephrology, London Health Sciences Centre, London, Ontario, Canada"},{"name":"Lawson Health Sciences Centre Research Institute, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Thain","sequence":"additional","affiliation":[{"name":"Medicine, Western University, London, Ontario, Canada"},{"name":"Geriatrics, St. Joseph's Health Care London, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayyab","family":"Khan","sequence":"additional","affiliation":[{"name":"Medicine, Western University, London, Ontario, Canada"},{"name":"Centre for Diabetes, Endocrinology and Metabolism, St. Joseph's Health Care London, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Silver","sequence":"additional","affiliation":[{"name":"ICES Western, London, Ontario, Canada"},{"name":"Nephrology, Kingston Health Sciences Centre, Kingston, Ontario, Canada"},{"name":"Medicine, Queen's University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber O","family":"Molnar","sequence":"additional","affiliation":[{"name":"ICES Western, London, Ontario, Canada"},{"name":"Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Nephrology, St. Joseph's Healthcare, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Sultan","sequence":"additional","affiliation":[{"name":"Medicine, Western University, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel M","family":"Holden","sequence":"additional","affiliation":[{"name":"Nephrology, Kingston Health Sciences Centre, Kingston, Ontario, Canada"},{"name":"Medicine, Queen's University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-3416","authenticated-orcid":false,"given":"Swapnil","family":"Hiremath","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Nephrology, The Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Wald","sequence":"additional","affiliation":[{"name":"Nephrology, St Michael\u2019s Hospital, Toronto, Ontario, Canada"},{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijat","family":"Kitchlu","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Arnold","sequence":"additional","affiliation":[{"name":"Lawson Health Sciences Centre Research Institute, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Field","sequence":"additional","affiliation":[{"name":"Lawson Health Sciences Centre Research Institute, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit X","family":"Garg","sequence":"additional","affiliation":[{"name":"Medicine, Western University, London, Ontario, Canada"},{"name":"ICES Western, London, Ontario, Canada"},{"name":"Nephrology, London Health Sciences Centre, London, Ontario, Canada"},{"name":"Lawson Health Sciences Centre Research Institute, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"2025091023001391000_15.9.e097195.1","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0002-9343(97)90022-X","article-title":"The crippling consequences of fractures and their impact on quality of life","volume":"103","author":"Cooper","year":"1997","journal-title":"Am J Med"},{"key":"2025091023001391000_15.9.e097195.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-319X(10)70004-X"},{"key":"2025091023001391000_15.9.e097195.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.04.006"},{"key":"2025091023001391000_15.9.e097195.4","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.547"},{"key":"2025091023001391000_15.9.e097195.5","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2862","article-title":"Hip Fracture in Patients With Non-Dialysis-Requiring Chronic Kidney Disease","volume":"31","author":"Kim","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2025091023001391000_15.9.e097195.6","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in Patients with CKD: Time for Action","volume":"11","author":"Moe","year":"2016","journal-title":"CJASN"},{"key":"2025091023001391000_15.9.e097195.7","unstructured":"Lilly E . Product monograph: risedronate. 2017."},{"key":"2025091023001391000_15.9.e097195.8","unstructured":"Lilly E . Product monograph: raloxifene. 2018."},{"key":"2025091023001391000_15.9.e097195.9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007050555"},{"key":"2025091023001391000_15.9.e097195.10","unstructured":"Lily E . Product monograph: forteo. 2010."},{"key":"2025091023001391000_15.9.e097195.11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"The Lancet"},{"key":"2025091023001391000_15.9.e097195.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809003"},{"key":"2025091023001391000_15.9.e097195.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809493"},{"key":"2025091023001391000_15.9.e097195.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.02.002"},{"key":"2025091023001391000_15.9.e097195.15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11657-020-00796-3","article-title":"Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study","volume":"15","author":"Clemens","year":"2020","journal-title":"Arch Osteoporos"},{"key":"2025091023001391000_15.9.e097195.16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40620-016-0334-1","article-title":"Safety and efficacy of denosumab in osteoporotic hemodialysed patients","volume":"30","author":"Festuccia","year":"2017","journal-title":"J Nephrol"},{"key":"2025091023001391000_15.9.e097195.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1154"},{"key":"2025091023001391000_15.9.e097195.18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/j.ajkd.2015.03.012","article-title":"Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial","volume":"66","author":"Hiramatsu","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2025091023001391000_15.9.e097195.19","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1613"},{"key":"2025091023001391000_15.9.e097195.20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-59143-8","article-title":"Denosumab for dialysis patients with osteoporosis: A cohort study","volume":"10","author":"Kunizawa","year":"2020","journal-title":"Sci Rep"},{"key":"2025091023001391000_15.9.e097195.21","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.403"},{"key":"2025091023001391000_15.9.e097195.22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1210\/clinem\/dgaa851","article-title":"Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease","volume":"106","author":"Broadwell","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2025091023001391000_15.9.e097195.23","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3676"},{"key":"2025091023001391000_15.9.e097195.24","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/pds.4045","article-title":"Denosumab\u2010associated hypocalcaemia: incidence, severity and patient characteristics in a tertiary hospital setting","volume":"25","author":"Huynh","year":"2016","journal-title":"Pharmacoepidemiology and Drug"},{"key":"2025091023001391000_15.9.e097195.25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/nep.12432","article-title":"Hypocalcaemic tetany occurring post a single denosumab dose in a patient with stage 4 chronic kidney disease, followed by calcium\u2010 and calcitriol\u2010induced hypercalcaemia","volume":"20","author":"Lambe","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"2025091023001391000_15.9.e097195.26","doi-asserted-by":"publisher","DOI":"10.1159\/000380960"},{"key":"2025091023001391000_15.9.e097195.27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/imj.13097","article-title":"Life\u2010threatening hypocalcaemia associated with denosumab in advanced chronic kidney disease","volume":"46","author":"Killen","year":"2016","journal-title":"Intern Med J"},{"key":"2025091023001391000_15.9.e097195.28","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.L.00193"},{"key":"2025091023001391000_15.9.e097195.29","unstructured":"National Institute of Health . Rethinking clinical trials. Available: https:\/\/rethinkingclinicaltrials.org\/ [Accessed 2 Jul 2020]."},{"key":"2025091023001391000_15.9.e097195.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39108.379965.BE"},{"key":"2025091023001391000_15.9.e097195.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2014.04.001"},{"key":"2025091023001391000_15.9.e097195.32","doi-asserted-by":"publisher","DOI":"10.1111\/j..2002.384.doc.x"},{"key":"2025091023001391000_15.9.e097195.33","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025091023001391000_15.9.e097195.34","unstructured":"World Health Organization . Fracture risk assessment tool. Available: https:\/\/www.sheffield.ac.uk\/FRAX\/tool.aspx?country=19 [Accessed 30 Aug 2022]."},{"key":"2025091023001391000_15.9.e097195.35","doi-asserted-by":"crossref","first-page":"115188","DOI":"10.1016\/j.bone.2019.115188","article-title":"FRAX prognostic and intervention thresholds in the management of major bone fractures in hemodialysis patients: A two-year prospective multicenter cohort study","volume":"133","author":"Przedlacki","year":"2020","journal-title":"Bone"},{"key":"2025091023001391000_15.9.e097195.36","unstructured":"Tri-council policy statement: ethical conduct for research involving humans \u2013 TCPS 2 (2018) \u2013 chapter 11: clinical trials. Available: https:\/\/ethics.gc.ca\/eng\/tcps2-eptc2_2018_chapter11-chapitre11.html [Accessed 15 Jan 2021]."},{"key":"2025091023001391000_15.9.e097195.37","doi-asserted-by":"publisher","DOI":"10.1177\/2054358119887988"},{"key":"2025091023001391000_15.9.e097195.38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11657-013-0143-2","article-title":"Canadian Chronic Disease Surveillance System (CCDSS) Osteoporosis Working Group. Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study","volume":"8","author":"O\u2019Donnell","year":"2013","journal-title":"Arch Osteoporos"},{"key":"2025091023001391000_15.9.e097195.39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.3318","article-title":"Effectiveness of Oral Bisphosphonates in Reducing Fracture Risk Among Oral Glucocorticoid Users: Three Matched Cohort Analyses","volume":"33","author":"Amiche","year":"2018","journal-title":"J Bone Miner Res"},{"key":"2025091023001391000_15.9.e097195.40","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamainternmed.2014.6930","article-title":"Falls and fractures with atypical antipsychotic medication use: a population-based cohort study","volume":"175","author":"Fraser","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2025091023001391000_15.9.e097195.41","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000808"},{"key":"2025091023001391000_15.9.e097195.42","unstructured":"eHealth Ontario . Ontario laboratory information system. Available: https:\/\/www.ehealthontario.on.ca\/for-healthcare-professionals\/ontario-laboratories-information-system-olis [Accessed 23 May 2018]."},{"key":"2025091023001391000_15.9.e097195.43","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20190065"},{"key":"2025091023001391000_15.9.e097195.44","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(81)90001-5"},{"key":"2025091023001391000_15.9.e097195.45","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ndt\/gfz023","volume":"34","author":"Zoccali","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2025091023001391000_15.9.e097195.46","doi-asserted-by":"crossref","DOI":"10.1177\/2054358119870539","article-title":"Association of Bone Mineral Density With Fractures Across the Spectrum of Chronic Kidney Disease: The Regina CKD-MBD Study","volume":"6","author":"Prasad","year":"2019","journal-title":"Can J Kidney Health Dis"},{"key":"2025091023001391000_15.9.e097195.47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/08860221003611661","article-title":"Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure","volume":"32","author":"Orlic","year":"2010","journal-title":"Ren Fail"},{"key":"2025091023001391000_15.9.e097195.48","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00198-018-4406-z","article-title":"The utility of FRAX\u00ae in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study","volume":"29","author":"Przedlacki","year":"2018","journal-title":"Osteoporos Int"},{"key":"2025091023001391000_15.9.e097195.49","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3110","article-title":"Clinical Features of 24 Patients With Rebound\u2010Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases","volume":"32","author":"Anastasilakis","year":"2017","journal-title":"J of Bone & Mineral Res"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-097195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:00:41Z","timestamp":1757570441000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-097195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,10]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/bmjopen-2024-097195"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-097195","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}